Lokivetmab (Cytopoint) side effects in dogs

6,510 reports sent to the FDA between 2014 and 2026 involve Lokivetmab in dogs. The most reported problems were vomiting, lethargy, loss of appetite. 47% were marked serious, and where it was recorded, signs eased after stopping the medicine in 33% of cases.

6,510Reports
47%Marked serious
0.1%Only medicine involved
15%Recovered
7.2%Died or euthanised
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

About this medicine

Lokivetmab controls allergic itch for 4–8 weeks per injection.

Products with this ingredient include Cytopoint. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Most reported side effects

Share = percentage of this medicine's reports that mention the problem. One report can list several problems.

Reports that it didn't work

Some reports are about the medicine not working (for example a dog still getting fleas or heartworm), not about a side effect.

Didn't prevent heartworm
15 0.2%
Didn't stop ticks
5 0.1%
Didn't stop mites
3 0.0%

How soon problems started

Same day
1,368 28%
1–2 days
610 13%
3–7 days
453 9.4%
1–4 weeks
804 17%
Over a month
1,575 33%

Time from the first dose to the first sign, where both dates were reported (4,810 reports).

How the animals did

Recovered
964 15%
Recovered with lasting effects
19 0.3%
Still unwell when reported
4,115 63%
Died
211 3.2%
Euthanised
257 3.9%
Not known
944 15%

Breeds named most often

Popular breeds appear more often because there are more of them.

Other monoclonal antibody injections for dogs